MELA SCIENCES INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Chart calendar MELA Sciences Inc
3c1fc8ec.h5GhOgo2bTtIG9LcDuYfFTpumh3anpnWZtbQLnXaCyg.wPvle2BBX10wfuqZapx0RV8Y_Ey9r-G5U-GhfECVOEP_0OpRblcFQxJ2gw~824d28ad9d28653c482c330ee6ab58c0
Upcoming events on MELA Sciences Inc
Past events on MELA Sciences Inc
| 06/06/2024 | Reverse Split: 1 of 10 |
| 20/05/2024 | Benchmark Healthcare House Virtual Investor Conference |
| 15/05/2024 21:30 | Q1 2024 Earnings Call |
| 15/05/2024 21:01 | Q1 2024 Earnings Release |
| 01/05/2024 22:30 | Planet MicroCap Showcase |
| 27/03/2024 20:30 | Q4 2023 Earnings Call |
| 27/03/2024 20:01 | Q4 2023 Earnings Release |
| 06/12/2023 | Benchmark Company Discovery Conference |
| 14/11/2023 21:30 | Q3 2023 Earnings Call |
| 14/11/2023 21:00 | Q3 2023 Earnings Release |
| 25/10/2023 | Annual General Meeting |
| 18/10/2023 | Fall Clinical Dermatology Conference |
| 12/10/2023 18:00 | Dawson James Small Cap Growth Conference |
| 05/10/2023 | Skin of Color Update Conference |
| 04/10/2023 16:00 | LD Micro Main Conference |
| 20/09/2023 15:00 | Investor Meeting - Key Opinion Leader |
| 13/08/2023 | Needham Virtual MedTech & Diagnostics Conference |
| 09/08/2023 21:30 | Q2 2023 Earnings Call |
| 09/08/2023 21:01 | Q2 2023 Earnings Release |
| 02/08/2023 | DERM NP PA CME Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 31,6 31,3 0.9% | 23,1 23,1 0.04% | 30,0 29,9 0.28% | 36,2 35,4 2.21% | 33,4 34,7 -3.81% | 31,2 |
|
EBITDA Million USD | Released Forecast Spread | 1,40 -3,80 136.76% | -0,14 -4,60 96.93% | -0,18 -0,70 74.86% | 2,56 1,22 109.59% | 0,96 1,38 -30.53% | -1,55 |
|
EBIT Million USD | Released Forecast Spread | -3,01 -3,62 16.85% | -4,08 -4,73 13.83% | -4,40 -4,45 1.15% | -4,65 -6,36 26.93% | -6,32 -5,84 -8.27% | -7,99 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,94 -4,27 7.85% | -4,14 -4,92 15.9% | -2,67 -2,69 0.5% | -5,49 -7,17 23.49% | -10,9 -7,42 -47.11% | -9,97 |
|
Net income Million USD | Released Forecast Spread | -3,60 -4,05 11.13% | -4,39 -4,83 8.98% | -2,71 -2,71 0.31% | -5,55 -7,17 22.61% | -10,8 -7,45 -45.38% | -10,0 |
|
EPS USD | Released Forecast Spread | -1,10 -1,27 13.16% | -1,30 -1,47 11.36% | -0,80 -0,75 -6.67% | -1,60 -2,05 21.95% | -3,10 -2,15 -44.19% | -2,80 |
| Announcement Date | 17/03/20 | 24/03/21 | 21/03/22 | 31/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,04 6,95 1.35% | 9,11 8,14 11.88% | 9,41 8,09 16.33% | 10,6 9,82 7.92% | 7,57 7,50 0.85% | 8,25 8,75 -5.66% | 8,85 8,72 1.53% | 8,70 10,0 -13.07% | 6,75 6,91 -2.27% | 7,42 | 8,33 | 8,66 | 7,70 | 8,67 |
|
EBITDA Million USD | Released Forecast Spread | -0,51 -0,84 39.52% | 0,21 0,05 314% | 1,06 -0,05 2186.27% | 1,79 0,44 311.47% | -0,76 -0,77 0.85% | -0,10 -0,07 -43.94% | 1,29 0,81 59.88% | 0,52 1,39 -62.7% | -1,28 0,00 -85166.67% | -0,41 | 0,04 | 0,09 | -0,03 | 0,52 |
|
EBIT Million USD | Released Forecast Spread | -2,30 -1,69 -35.95% | -1,69 -1,52 -11.12% | -0,79 -1,88 58.15% | 0,13 -1,59 108.43% | -2,59 -2,28 -13.27% | -1,96 -1,82 -8.04% | -0,62 -1,19 48.1% | -1,16 -0,67 -72.43% | -2,89 -1,83 -57.74% | -1,99 | -1,57 | -1,54 | -1,86 | -1,33 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,50 -1,95 -28.05% | -1,89 -1,78 -6.02% | -1,00 -2,12 53.03% | -0,10 -1,79 94.58% | -2,84 -2,49 -13.72% | -3,15 -2,03 -55.38% | -1,05 -1,40 24.52% | -3,89 -0,84 -362.07% | -3,37 -2,26 -49.26% | -2,49 | -2,07 | -2,04 | -2,26 | -1,73 |
|
Net income Million USD | Released Forecast Spread | -2,50 -1,93 -29.7% | -1,89 -1,76 -7.53% | -1,00 -2,14 53.4% | -0,16 -1,79 91.06% | -2,84 -2,52 -12.59% | -3,15 -2,05 -53.49% | -1,05 -1,42 25.85% | -3,79 -0,87 -338.11% | -3,37 -2,28 -47.62% | -2,51 | -2,10 | -2,07 | -2,31 | -1,78 |
|
EPS USD | Released Forecast Spread | -0,70 -0,60 -16.67% | -0,50 -0,50 0% | -0,30 -0,60 50% | 0,00 -0,50 - | -0,80 -0,70 -14.29% | -0,90 -0,55 -63.64% | -0,30 -0,40 25% | -1,10 -0,20 -450% | -1,00 -0,65 -53.85% | -0,70 | -0,60 | -0,55 | -0,60 | -0,40 |
| Announcement Date | 11/05/22 | 10/08/22 | 09/11/22 | 31/03/23 | 15/05/23 | 09/08/23 | 14/11/23 | 27/03/24 | 15/05/24 | - | - | - | - | - |
| 23/07/2024 11:00 | DANAHER CORPORATION: Q2 2024 Earnings Release |
| 23/07/2024 | OXFORD NANOPORE TECHNOLOGIES PLC: Q2 2024 Sales and Revenue Release - Trading Update |
| 23/07/2024 | NANJING VISHEE MEDICAL TECHNOLOGY CO., LTD: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 11:00 | THERMO FISHER SCIENTIFIC: Q2 2024 Earnings Release |
| 24/07/2024 11:30 | BOSTON SCIENTIFIC CORPORATION: Q2 2024 Earnings Release |
| 24/07/2024 21:15 | EDWARDS LIFESCIENCES CORPORATION: Q2 2024 Earnings Release |
| 25/07/2024 06:30 | DRÄGERWERK AG & CO. KGAA: Q2 2024 Earnings Release |
| 25/07/2024 13:00 | INTEGER HOLDINGS CORPORATION: Q2 2024 Earnings Release |
| 28/07/2024 | REVVITY, INC.: Q2 2024 Earnings Release |
| 29/07/2024 06:00 | PHILIPS NV: Q2 2024 Earnings Release |
Past sector events for MELA Sciences Inc
| Today | INTUITIVE SURGICAL, INC.: Q2 2024 Earnings Release |
| 14/07/2024 23:50 | NANOSONICS LIMITED: Q4 2024 Sales and Revenue Release - Trading Update |
| 05/06/2024 06:30 | ELEKTA AB: Q4 2024 Earnings Release |
| 29/05/2024 21:05 | AGILENT TECHNOLOGIES, INC.: Q2 2024 Earnings Release |
| 14/05/2024 | FUKUDA DENSHI CO., LTD.: Q4 2023 Earnings Release |
| 12/05/2024 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
| 09/05/2024 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
| 08/05/2024 21:05 | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:01 | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
| 08/05/2024 06:00 | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
- Stock Market
- Equities
- SSKN Stock
- Stock
- Calendar MELA Sciences Inc
